Paragon Biosciences Emalex Capital, Inc. — Form D/A
Paragon Biosciences Emalex Capital, Inc. of CHICACO, IL, a company, filed a Form D amendment with the SEC on 2025-07-08. The offering totals $270.0M, of which $270.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-07-08
- Form: D/A
- Accession: 0001749990-25-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $270.0M
- Amount sold: $270.0M
- Minimum investment: $1K
- Investors: 42
- Date of first sale: 2022-05-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-463914
Issuer
- Name: Paragon Biosciences Emalex Capital, Inc.
- CIK: 0001749990
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 303 N WABASH AVE, CHICACO, IL, 60611
- Phone: (847) 715-0606
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Jeffrey J Aronin | Director | Chicago, IL |
| Jeffrey J Dayno | Director | Chicago, IL |
| Antonio J Gracias | Director | Chicago, IL |
| Eric J Messner | Director | Chicago, IL |
| Ricky J Sun | Director | Chicago, IL |
| Eric J Messner | Executive Officer | Chicago, IL |
| Patrick J Morris | Executive Officer | Chicago, IL |
| Darien J Parhad | Executive Officer | Chicago, IL |
| ANTONIO GRACIAS | Director | Hawthorne, CA |
| Jeffrey J Aronin | Executive Officer | Chicago, IL |
| Jeffrey Aronin | Director | Exton, PA |
| Patrick Morris | Director | Chicago, IL |
| Patrick Morris | Executive Officer | Chicago, IL |
| Darien Parhad | Executive Officer | Exton, PA |
| Timothy Cunniff | Director | Chicago, IL |
| Patrick J Morris | Director | Chicago, IL |
Other filings by this issuer (9)
More